1. Tepetes K, Asprodini EK, Christodoulidis G ve ark. Prevention of postoperative adhesion formation by individual and combined administration of 4 per cent icodextrin and dimetindene maleate. Br J Surg. 2009; 96(12): 1476–83.
2. Menzies D, Ellis H. Intestinal obstruction from adhesions – how big is the problem? Ann R Coll Surg Engl 1990; 72: 60–63.
3. D. Peritoneal adhesions: incidence, cause and prevention. Surg Annu 1992; 24:
2745.
4. Holtz G. Prevention and management of peritoneal adhesions. Fertil Steril 1984;
41: 497–507.
5. TitoWA, Sarr MG. Intestinal obstruction. In Surgery of the Alimentary Tract, Zuidema GD (ed.). WB Saunders: Philadelphia, 1996; 375–416.
6. Canis M, Botchorishvili R, Wattiez A ve ark. Prevention of peritoneal adhesions.
J Gynecol Obstet Biol Reprod 2001; 30: 305–324.
7. Roman H, Canis M, Kamble M ve ark. Efficacy of three adhesion-preventing agents in reducing severe peritoneal trauma induced by bipolar coagulation in a laparoscopic rat model. Fertil Steril 2005; 83: 1113–1118.
8. Coleman MG, McLain AD, Moran BJ. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Dis Colon Rectum 2000;43: 1297–99.
9. Van Goor H. Consequences and complications of peritoneal adhesions.
Colorectal Dis 2007; 9: 25–34.
10. Christen D, Buchmann P. Peritoneal adhesions after laparotomy: prophylactic measures. Hepatogastroenterology 2001; 38: 283–286.
11. Censur Z. Postoperatif intraabdominal adezyonların önlenmesinde değişik dozlardaki heparin ve seprafilmin etkinliğinin karşılaştırılması. Lutfi Kırdar Eğitim Araştırma Hastanesi 3. Cerrahi Kliniği. Uzmanlık tezi. İstanbul. 2005.
12. Risberg B. Adhesions: Preventive strategies. Eur j Surg 1997; 577: 32–3
13. Harris ES, Morgan RF, Rodeheaver GT. Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents.
Surgery 1995; 117: 663–669.
14. Gilbert JA, Peers EM, Brown CB, Beran Y. Intraperitoneal fluid dynamics of 4% icodextrin in non-ESRD patients. Periton Dial Int 1999; 19(Suppl 1): 79.
15. Verco SJS, Peers EM, Brown CB ve ark. Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies.
Human Reprod 2000; 15: 1764–1772.
16. diZerega GS. The peritoneum: post surgical repair and adhesion formation. In Female Reproductive Surgery, Rock JA, Murphy AA, Jones HW(eds).Williams
&Wilkins: Baltimore, 1992; 2–18.
17. Kutlay J, Ozer Y, Isik B, Kargici H. Comparative effectiveness of several agents for preventing postoperative adhesions. World J Surg 2004; 28: 662–665.
18. Menzies D, Pascual MH, Walz MK ve ark. ARIEL Registry. Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery:
from the multicenter ARIEL Registry. Ann R Coll Surg Engl 2006; 88: 375–
382.
19. Holtz G. Prevention of postoperative adhesions. J Reprod Med 1980; 24: 141–
146.
20. Burns JW, Skinner K, Colt MJ Burgess L ve ark. A hyaluronate based gel for the prevention of postsurgical adhesions: evaluation in two animal species. Fertil Steril 1996; 66: 814–821.
21. Hosie K, Gilbert JA, Kerr D ve ark. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Deliv 2001; 8: 9–12.
22. Al-Musawi D, Thompson JN. Adhesion prevention: state of the art.
Gynaecological Endoscopy 2001; 10: 123–130.
23. Trew G. Postoperative adhesions and their prevention. Rev Gynecol Perinat Pract 2006; 6: 47–56.
24. Gomel V, Urman B, Gurgan T. Pathophysiology of adhesion formation and strategies for prevention. J Reprod Med 1996; 41: 35–41.
25. Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl 1997; 577: 24–31.
26. Liakakos T, Thomakos N, Fine PM ve ark. Peritoneal adhesions: etiology, pathophysiology and clinical significance. Recent advances in prevention and management. Dig Surg 2001; 18: 260–273.
27. Gazzaniga AB, James JM, Shobe JB ve ark.. Prevention of peritoneal adhesions in the rat. The effects of dexamethasone, methylprednisolone, promethazine, and human fibrinolysin. Arch Surg 1975; 110: 429–432.
28. diZerega GS. Biochemical events in peritoneal tissue repair. Eur J Surg Suppl 1997; 577: 10–16.
29. Avsar FM, Sahin M, Aksoy F ve ark. Effects of diphenhydramine HCl and methylprednisolone in the prevention of abdominaladhesions. Am J Surg 2001;
181: 512–515.
30. Chanvit Tanphiphat, Soottipom Chittmittrapap ve ark. Adhezive Small bowel obstruction. Am. J.Surg. 1987;154: 283–7
31. Peter J. Fabri, Alexander Rosemurgy, Reoperation for small intestinal obstruction. Surg. Clin North Am.1991; 71: 131–46
32. Peter J Mucha, Small intestinal obstruktion. Surg. Clin. North Am.1987; 67:
597–620
33. John F Perry, Grafton A, Smith ve ark. İntestinal Obstruction caused by adhesion. Ann of Surg. 1955; 142: 810–6
34. Nancy Fox Ray, John W Larsen, Robert J Stilman. Economic impact of hospitalizasyon for lower abdominal adhesioliysis in the USA in 1988. Surg Gynecol obstet 1993; 176: 271–6
35. Willy Arung, Michel Meurisse, and Olivier Detry. Pathophysiology and prevention of postoperative peritoneal adhesions, World J Gastroenterol 2011;
17(41): 4545–53
36. Parker MC, Ellis H, Moran BJ ve ark. Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery. Dis Colon Rectum 2001; 44: 822–9.
37. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D et al.
Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353: 1476–80.
38. Parker M, Sunderland G, Wilson M, Menzies D, Thompson J, Clark D et al., on behalf of the Surgical and Clinical Adhesions Research (SCAR) Group.
Colorectal surgery: the risk and burden of adhesion-related complications.
Colorect Dis 2004; 6: 506–11.
39. Wilson MS, Menzies D, Knight A, Crowe AM. Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorect Dis 2002; 4: 355–
60.
40. W. Luijendijk,D.C.D de Lange, Foreign materials in postoperatif adhesions.
Ann. Surg. 1996, 223:242-8
41. Coleman MG, McLain AD, Moran BJ. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Dis Colon Rectum 2000; 43:1297-9.
42. Rohr MS, McDonald JC. Abdominal wall, umbilicus, peritoneum, and mesenteries. Sabiston DC (ed). Textbook of Surgery. W.B. Saunders Company 13.th edition. 1986; Vol 1: 774-789.
43. Hiyama DT, Bennion RS. Peritonitis and intraperitoneal abscess. Zinner MJ, Schwartz SI, Ellis H (ed). Maingot’s Abdominal Operations. Appleton& Lange 10.th edition. 1997; Vol 1: 633-653.
44. Sezgin İ.Gastrointestinal sistem anatomisi. Sayek İ (ed). Temel Cerrahi. Güneş Kitabevi, Ankara, 1996: Cilt 1 : 895-906.
45. Di Zerega GS: Biocemical events in peritoneal tissue repair.Eur J Surg Suppl 1997; 577:10-6
46. Hertzler AE, The peritoneum. St. Louis: DV Mosby . 1919: 20-69
47. Holmdahl L, Ericsson E, Al-Jabreen M, Risberg B. Fibrinolysis in human peritoneum during operation surgery. 1996; 119: 701-5
48. Rodgers KE, di Zeregga GS, Function of peritoneal eksudate cells after abdominal surgery J Invest. Surg 1993; 6: 9-23
49. Holmdahl L, Ericsson E, Ericsson BI, Risberg B. Depression of peritoneal fibrinolysis during operation is a local response to trauma Surgery 1998; 13:
539-44
50. Buckman RF, Woods M, Sargendt L, A unifying pathogenetic mechanism inthe etiology of intraperitoneal adhesions. J Surg Res 1976; 201-5
51. Raftery AT: effect of peritoneal travma on peritoneal fibrinolytic activity and intraperitoneal adhesions formation. Eur Surg Res 1987; 13: 397-401
52. Milligan DW, Raftery AT: Obstervations on the pathogenesis of peritoneal adhesions a light and electeron microscopical study. Br J Surg 1974; 61: 274-80 53. Di Zerega GS, Contemporery adhesions prevention Fertil Steril 1994; 61:
219-35
54. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adesions; etiology, pathophysiology, and clinical significanse. Dig Surg 2001;18: 260-73
55. Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, van Goor H. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000; 87: 467-71.
56. De Cherney AH, di Zerega GS. Clinical problem of intraperitoneal postsurgical adhesion formation foolowing general suegery and thee use of adhesion prevention bariers. Surg Clin North Am 1997; 77: 671-88
57. Hershlag A,Otternes I,Blivers M et al.The effect of interleukin-1 adhesion
58. Kovacs EJ, Brook B, Silber IA, et al. Production of fibrogenic cytokines by interleukin-2treated peripheral leukoyctes: expression of transforming growth factor-β chain genes. Obstet Gynecol 1993; 82: 29-36
59. Montesano R, Oral L. Transforming growth factor-β stimulates colagen-matrix contraction by fibroblasts:implications for wound healing.Proc Natl Sc USA 1988; 85: 597-62
60. Schwartz, 9. Baskı, 389 sayfa
61. Ellis H. The magnitude of adhesion related problems. Ann Chir Gynaecol 1998;
1: 9-11
62. Thompson JN. Patterson-Brown S, Horbourne T, et al. Reduced human peritoneal plaminogen activity: possible mechanism of edhesion formation. Br J Surg1989; 76:382-84
63. Vipond MN, Whawail SA, Thompson JN. Peritoneal fibrinolytic activity and intraabdominal adhesion. Lncet 1990; 335; 1120-24
64. Ellis H.The cause and prevention of postoperative abdominal adhesions.Br Surg1962 50:10-3
65. Pagidas K, Tulandi T. Effect of ringer ‘s lactate, Interceed (TC7) and Gore-Tex surgical membrane on postsurgical adhesion formation.Fertil Steril 1992; 57:
199-201.
66. Sağlam A, Yeşilkaya Y: Evaluation of different sets of trauma on adhesion formation in rats. Erciyes Tıp Dergisi 1990;12: 569-77.
67. Risberg B: Adhesions preventive strategies. Eur J Surg Suppl 1997;577: 32-39.
68. di Zerega, G Fertil Steril: Contemporary adhesion prevention. 1994; 61: 219-35.
69. Menzies D: Peritoneal adhesions.Incidence, cause and prevention. Ann Surg 1992; 24 : 29-45.
70. Burns JW, Cold MJ, Burgess LS, Skinner KC. Preclinical evaluation of seprafilm beoresorbable membrane.Eur J Surg.1997; 577: 40-8
71. Avsar FM, Sahin M, Aksoy F, Avsar AF, Aköz M, Hengirmen S, Bilici S. Effects of diphenhydramine HCl and methylprednisolone in the prevention of abdominal adhesions. Am J Surg. 2001 Jun;181(6):512-5.
72. Hosie K, Gilbert JA, Kerr D, Brown CB, Peers EM. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Deliv 2001; 8: 9–
12.
73. Beck DE, Cohen Z, Fleshman JW, Kaufman HS, van Goor H, Wolff BG. A prospective, randomized, multicenter, controlled study of the safety of seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum 2003; 46: 1310–9.
74. diZerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17: 1031–8.
75. Verco SJ, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G.
Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: preclinical studies. Hum Reprod 2000; 15: 1764–72.
76. Nacar H. Akciğer kisthidatik operasyonlarında sevofluran ve desfluran anestezilerinin oksidatif stres ve prolidaz enzim aktivitesi üzerine etkileri.
Harran Üniversitesi Tıp Fakültesi Genel Cerrahi Anabilim Dalı. Uzmanlık Tezi.
Şanlıurfa.
77. Angel MF, Ramasastry SS, Swartz WM, Basford RE, Futrell JW. Free radicals:
basic concepts concerning their chemistry, pathophysiology, and relevance to plastic surgery. Plast Reconstr Surg. 1987;79:990-7
78. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull. 1993;49:481-93.
79. Erden M. Serbest radikaller. T Klin Tıp Bilimleri. 1992; 12: 201-207.
80. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994; 344:721-4
81. McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance.
Clin Biochem. 1993;26:351-7.
82. Williams AT, Burk RF. Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury, Semin Liver Dis, 1990; 10: 4, 279-284.
83. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991 Sep 30;91(3C):14S-22S
84. Barber D, Harris S. Oxygen free radicals and antioxidants: a review, Am Pharm, 1994; 34: 9, 26-35.
85. Bellavite P. The superoxide-forming enzymatic system of phagocytes, Free Radic Biol Med, 1988; 4: 4, 225-261.
86. Das DK, Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury, Methods Enzymol, 1994; 233: 601-610.
87. Grace PA. Ischaemia-reperfusion injury, Br J Surg, 1994; 81: 5, 637-647.
88. Ward A, McBurney A, Lunec J. Evidence for the involvement of oxygen-derived free radicals in ischaemia-reperfusion injury, Free Radic Res, 1994; 20:
1, 21-28.
89. Akkuş İ: Serbest Radikaller ve Fizyopatolojik Etkileri. 1. Ed Mimoza Yayınları, Konya, 1995
90. Nakazawa H, Genka C, Fujishima M. Pathological aspects of active oxygens/free radicals, Jpn J Physiol, 1996; 46: 1, 15-32.
91. Baynes JW. Role of oxidative stress in development of complications in diabetes, Diabetes, 1991; 40: 4, 405-412.
92. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance, Am J Clin Nutr, 1993; 57: 5 Suppl, 715S-724S; discussion 724S-725S.
93. Suryaprabha P, Das UN, Ramesh G, et al. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus, Prostaglandins Leukot Essent Fatty Acids, 1991;
43: 4, 251-255.
94. Yao JK, Reddy R, McElhinny LG, et al. Reduced status of plasma total antioxidant capacity in schizophrenia, Schizophr Res, 1998; 32: 1, 1-8.
95. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions, Clin Biochem, 2004; 37: 2, 112-119.
96. Ghiselli A, Serafini M, Natella F, et al. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data, Free Radic Biol Med, 2000; 29: 11, 1106-1114.
97. Hardenbergh PH, Munley MT, Bentel GC, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin:
preliminary results. Int J Radiat Oncol Biol Phys. 2001;49:1023-8.
98. Iwahashi M, Ooshima A, Nakano R. Increase in the relative level of type V collagen in the placentae of patients with pre-eclampsia. Moleculer Human Repruduction vol.3 no.8 pp. 725- 728, 1997
99. Kodama H. Mikasa H. Biocheemical Investigations on Prolidase and Prolinase in Erythrocytes from Patients with Prolidase Deficiency. Clin Chim Acta, 1988;
173: 317- 24.
100. Chamson A, Voigtlander V.Collagen Biosynthesis Anomalies in Prolidase Deficiency. Effect of Glycl-L-Proline on the Degradation of Newly Synthesized Collagen Clin. Physiol Biochem 1989; 7:128-36
101. Göçebe M. Prolidaz enziminin serum aktivite değerlerini kardiyak hipertrofili hastalarda tespit ederek hastalığın erken tanısı açısından prolidaz enzim aktivitesin bir rolü olup olamayacağını incelemek. Harran Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı. Uzmanlık Tezi. Şanlıurfa. 2007
102. Majuzi MK, Kalambahati K, Powar B. Prevention of adhesions whith polivinilpyrolidone. Arch Surg 1964;89: 1011-5.
103. Yildiz F, Terzi A, Coban S, Bitiren M, Celik H, Aksoy N, Ozdogan MK, Cakir H Purified Micronized Flavonoid Fraction Ameliorates the Injury of Spleen and Ileum Secondary to Hepatic Ischemia-Reperfusion in Rats. . Dig Dis Sci. 2009 Oct 22.
104. Chinard P: Photometric determination of proline and ornithine. J Biol Chem.
1952;199: 61-65.
105. Myara I, Charpentier C, Lemonnier A. : Optimal contions for prolidase assay by proline colorimetric determination: Application to iminodipeptiduria. Clin Chim Acta. 125:193-205, 1982.
106. Ohhashi T, Ohno T, Arata J, Sugahara K, Kodama H. Characterization of prolidase I and II from erythrocytes of a control, a patient with prolidase deficiency and her mother. Clin Chim Acta. 1990;187(1):1-9.
107. Mock WL, Green PC. : Mechanism and inhibition of prolidase. J Biol Chem.
265 (32): 19606-19610, 1990.
108. Hamilton PB, Ortiz PJ: Proline and hydroxyproline: purification, reaction with ninhydrine and some properties of their N-nitrosoderivatives. J Biol Chem. 184 (2): 607-615. 1950.
109. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions, Clin Biochem, 2004; 37: 2, 112-119.
110. Erel O. A new automated colorimetric method for measuring total oxidant status. J. Clinical Biochemistry. 2005; 47:119-29
111. Schnüriger B, Barmparas G, Branco BC ve ark. Prevention of postoperative peritoneal adhesions: a review of the literature. Am J Surg. 2011 Jan; 201 (1):
111-21.
112. Sulaiman H, Dawson L, Laurent GJ ve ark. Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans 2002; 30:26–131.
113. Verco SJ, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G.
Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies. Hum Reprod. 2000 Aug;15(8):1764-72.
114. Menzies D, Pascual MH, Walz MK ve ark; ARIEL Registry. Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery:
from the multicentre ARIEL Registry. Ann R Coll Surg Engl. 2006 Jul;88(4):375-82.
115. Brown CB, Luciano AA, Martin D ve ark. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril 2007; 88:1413–26.
116. Catena F, Ansaloni L, Di Saverio S ve ark. On Behalf of the World Society of Emergency Surgery. P.O.P.A. Study: Prevention of Postoperative Abdominal Adhesions by Icodextrin 4% Solution After Laparotomy for Adhesive Small Bowel Obstruction. A Prospective Randomized Controlled Trial. J Gastrointest Surg. 2011 Nov 4. [Epub ahead of print]
117. Trew G, Pistofidis G, Pados G, Lower A ve ark. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Hum Reprod. 2011 Aug;26(8):2015-27. Epub 2011 Jun 1.
118. Adam FU, Singan M, Özelsancak R. Icodextrin-Associated Sterile Peritonitis: a Recent Outbreak in Turkey. Perit Dial Int. 2007 Sep-Oct;27(5):598-9.
119. Avsar AF, Avsar FM, Sahin M ve ark. Diphenhydramine and hyaluronic acid derivatives reduce adnexal adhesions and prevent tubal obstructions in rats. Eur J Obstet Gynecol Reprod Biol. 2003 Jan 10;106(1):50-4.
120. Rasti M, Parvaresh E, Tavajoh S ve ark. The comparison of diphenhydramine HCl and Nedocromil sodium in prevention of abdominal postoperative adhesion formation in rat models: an experimental study. Int J Surg. 2007 Dec;5(6):384-7. Epub 2007 May 10.
121. Deniz K. Yumuşak doku sarkomlarında vasküler endotelyal growth faktör ekspresyonunun tümör histolojik derecesi ve tümör hücre proliferasyonu ile ilişkisi. Uzmanlık tezi. Kayseri. 2003.